BIOVIC B — Biovica International AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK135.33m
- SEK38.31m
- SEK3.38m
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -21.5 | -30.3 | -39.4 | -60.1 | -110 |
Depreciation | |||||
Non-Cash Items | 0.373 | -0.349 | 0.146 | 0.052 | 0.007 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.165 | 1.66 | -1.31 | 1.48 | 7.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -18 | -24.8 | -34.4 | -52.1 | -94.6 |
Capital Expenditures | -7.33 | -7.04 | -3.56 | -3.4 | -2.78 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0 | — | — | — |
Sale/Maturity of Investment | |||||
Cash from Investing Activities | -7.33 | -7.04 | -3.56 | -3.4 | -2.78 |
Financing Cash Flow Items | — | — | — | — | -25.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 55.7 | 143 | -0.136 | 122 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -25.3 | 23.9 | 105 | -55.6 | 24.5 |